<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>63-ANTIPARKINSONIAN-ANTICHOLINERGICS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ANTIPARKINSONIAN ANTICHOLINERGICS" code="N04AA-001" /></DRUG1>
<DRUG2>
<CLASS name="DOPAMINERGIC ALKALOIDS OF ERGOT OF RYE" code="G02CB-001" /></DRUG2>
<DESCRIPTION>Risk of increase of neuropsychological disorders.

</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Regular clinical and biological monitoring, especially at the beginning of the administration of these substances together. </COMMENT>
</INTERACTION>
</INTERACTIONS>
